Silva, Patricia B. da [UNESP]Freitas, Eduardo Sinesio de [UNESP]Solcia, Mariana Cristina [UNESP]Souza, Paula Carolina de [UNESP]Silva, Monize Martins daBatista, Alzir AzevedoEismann, Carlos E. [UNESP]Rolisola, Ana Marta C. M. [UNESP]Menegario, Amauri A. [UNESP]Cardoso, Rosilene FressattiChorilli, Marlus [UNESP]Pavan, Fernando R. [UNESP]2019-10-062019-10-062019-05-31Frontiers In Microbiology. Lausanne: Frontiers Media Sa, v. 10, 1 p., 2019.1664-302Xhttp://hdl.handle.net/11449/1867701engruthenium(II) complexestuberculosisnanotechnologyoral bioavailabilityICP-MSA Nanostructured Lipid System to Improve the Oral Bioavailability of Ruthenium(II) Complexes for the Treatment of Infections Caused by Mycobacterium tuberculosis (vol 9, 2930, 2018)Errata10.3389/fmicb.2019.01213WOS:000470130600001Acesso aberto